Maria Naskou, DVM, PhD, Dipl. ACVP
Assistant Professor of Clinical Pathology
Department of Pathobiology
Auburn University
College of Veterinary Medicine
1130 Wire Road
Auburn, AL 36849
Education
PhD, Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, USA
DVM, Faculty of Veterinary Medicine, University of Thessaly, Greece
Diplomate, American College of Veterinary Pathologists (Clinical Pathology)
Biography
Dr. Naskou received her DVM from the Faculty of Veterinary Medicine at the University of Thessaly in Greece in 2014 before completing her PhD in Comparative Biomedical Sciences and Regenerative Medicine at the University of Georgia in 2018. In 2018 she joined the College of Veterinary Medicine at Auburn University as a Postdoctoral Clinical Pathology Resident, while she was a Postdoctoral Fellow at Doug Martin’s laboratory at Scott-Ritchey Research Center at the same period. Dr. Naskou was board certified by the American College of Veterinary Pathologists in 2021. Subsequently Dr. Naskou was appointed Assistant Professor of Clinical Pathology at the Department of Pathobiology, College of Veterinary Medicine, Auburn University while she holds a joint appointment at the Scott-Ritchey Research Center, where her research lab is located. Dr. Naskou has obtained several awards from the Regenerative Bioscience Center and the Comparative Biomedical Sciences Program at the University of Georgia as well as from the American College of Veterinary Pathologists and the American Society of Veterinary Clinical Pathology.
Research Interests
Dr. Naskou’s research activities are focused on the investigation of platelet and stem cell based therapeutic approaches for the treatment of inflammatory and immune mediated conditions. Main areas of research include Extracellular Vesicles derived from Stem Cells, Platelet Lysate, Immunology and Regenerative Medicine. Her efforts are focused on the optimization of cell culture conditions for the clinical preparation of stem cell-based therapeutics, the use of Stem Cell derived Extracellular Vesicles against neuroinflammation as seen in many neurodegenerative disorders including Sandhoff disease, and to elucidate the exact mechanism by which attenuation of inflammation can be achieved with such novel therapeutics. Dr. Naskou also leads various clinical pathology related projects such as case reports and retrospective studies. Her work has been presented in national and international congresses and symposia, and published in peer reviewed journals, such as Stem Cells Research and Therapy, Veterinary Immunology and Immunopathology, Stem Cells & Development and Veterinary Clinical Pathology.